GlassScriptPhysician profile
Julia Yu
NPI 1326647488
$711.77
in general payments reported to CMS, 2019-2025
12 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.86 · 2022: $184 · 2023: $153 · 2024: $186 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $160.08 | 2022-2024 | Slynd |
| Exact Sciences Corporation | $117.77 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $103.69 | 2022-2024 | |
| Astellas Pharma US INC | $68.95 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $66.09 | 2024 | |
| Organon LLC | $51.00 | 2021-2022 | |
| Novo Nordisk INC | $32.40 | 2025 | |
| Myovant Sciences INC. | $30.68 | 2021 | |
| Lilly USA, LLC | $24.97 | 2025 | Zepbound |
| Scynexis, INC. | $22.07 | 2022 | |
| Amgen INC. | $18.27 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.